In plain language
This review proposes estimating interventional cardiologists' radiation dose through simulation, using a conversion factor from the patient dose area product recorded during each procedure. No measured data or validation are reported in the abstract.
At a glance
- Type of study
- Narrative review
- Who was studied
- Interventional cardiologists
- Summary based on
- the abstract
What it found
The authors propose that cardiologist dose could be estimated by simulation from the patient dose area product recorded by modern fluoroscopy systems.
A conversion factor relating patient dose-area product (DAP) to cardiologist dose is proposed, so that operator dose could be recorded alongside patient DAP for each procedure.
The review gives growing procedure numbers and high radiation doses as the reason fluoroscopy use needs to be managed.
Limits to keep in mind
This is a short narrative review abstract that reports no data, methods or validation of the proposed DAP-based conversion factor. Its conclusions are conceptual.
Related research summaries
- Obesity as a determinant of radiation burden in the cardiac catheterization laboratory (2026, Narrative review)
- Radiation Safety in Chronic Total Occlusion Percutaneous Coronary Intervention (2025, Narrative review)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Eye protection in interventional procedures (2021, Narrative review)
- Ionizing Radiation in Interventional Cardiology and Electrophysiology (2019, Narrative review)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.